Stephen G Rostand
Affiliation: University of Alabama at Birmingham
- Vitamin d deficiency in the pathogenesis of hypertension: still an unsettled questionStephen G Rostand
The Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, The University of Alabama at Birmingham, 266 Paula Building, 1720 2nd Avenue South, Birmingham, AL, 35294, USA
Curr Hypertens Rep 16:464. 2014....
- Vitamin D, blood pressure, and African Americans: toward a unifying hypothesisStephen G Rostand
The Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
Clin J Am Soc Nephrol 5:1697-703. 2010....
- Introduction to Vitamin D Symposium, March 14, 2008Stephen G Rostand
Division of Nephrology, University of Alabama at Birmingham, AL 35294, USA
Clin J Am Soc Nephrol 3:1534. 2008....
- Racial differences in renal arteriolar structure in children with minimal change nephropathyStephen G Rostand
Nephrology Research and Training Center, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35223, USA
Kidney Int 68:1154-60. 2005..The aim of this study was to determine if renal vascular changes were more pronounced in African Americans, were independent of blood pressure, and occurred in early childhood...
- Racial disparities in the association of foetal growth retardation to childhood blood pressureStephen G Rostand
Division of Nephrology, University of Alabama at Birmingham, 1530 3rd Avenue South, Birmingham, AL 35294, USA
Nephrol Dial Transplant 20:1592-7. 2005..For this reason we re-examined the role of FGR in childhood blood pressure...
- The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertensionJanice Lea
Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
Arch Intern Med 165:947-53. 2005..The objective of this study was to relate baseline and early changes in proteinuria and glomerular filtration rate (GFR) to long-term progression of hypertensive nondiabetic kidney disease...
- Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trialJackson T Wright
Case Western Reserve University, Department of Medicine, University Hospitals of Cleveland and the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, OH 44106 5014, USA
JAMA 288:2421-31. 2002..Hypertension is a leading cause of end-stage renal disease (ESRD) in the United States, with no known treatment to prevent progressive declines leading to ESRD...
- Oligonephronia, primary hypertension and renal disease: 'is the child father to the man?'Stephen G Rostand
Nephrol Dial Transplant 18:1434-8. 2003
- Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African AmericansLawrence J Appel
Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins Institutions, Johns Hopkins University, Baltimore, MD 21205 2223, USA
Arch Intern Med 168:832-9. 2008..A low blood pressure (BP) goal (BP, <130/80 mm Hg) is also recommended. The objective of this study was to determine the long-term effects of currently recommended BP therapy in 1094 African Americans with hypertensive CKD...
- The rationale and design of the AASK cohort studyLawrence J Appel
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland, 21205, USA
J Am Soc Nephrol 14:S166-72. 2003..Such results might eventually lead to new strategies that delay or prevent ESRD...